Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (89)
  • Apoptosis
    (61)
  • Autophagy
    (38)
  • Antibacterial
    (34)
  • NF-κB
    (27)
  • Antioxidant
    (21)
  • COX
    (20)
  • Reactive Oxygen Species
    (20)
  • Antifection
    (18)
  • Others
    (495)
Filter
Search Result
Results for "

15:1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1088
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    32
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    4
    TargetMol | Dye_Reagents
  • PROTAC Products
    11
    TargetMol | PROTAC
  • Natural Products
    662
    TargetMol | Natural_Products
  • Reagent Kits
    1
    TargetMol | Reagent_Kits
  • Recombinant Protein
    105
    TargetMol | Recombinant_Protein
  • Isotope Products
    6
    TargetMol | Isotope_Products
  • Antibody Products
    55
    TargetMol | Antibody_Products
  • Disease Modeling
    5
    TargetMol | Disease_Modeling_Products
  • Cell Research
    5
    TargetMol | Inhibitors_Agonists
Tunicamycin 15:1 Mixture
T38082
Tunicamycin 15:1 is a mixture of tunicamycin structural isomers that contain a 15-carbon N-acyl chain with variable branching patterns. The N-acyl chain incorporated into tunicamycins, like tunicamycin 15:1, is derived from the same pool of cellular branched-chain fatty acids (BCFAs) inStreptomycesand directly impacts the biological activity of each individual tunicamycin variant.1,2,3Purified tunicamycin 15:1 withiso,anteiso, or a mixture ofisoandanteisobranching configurations inhibit bacterial phospho-MurNAc-pentapeptide transferase (MraY) with IC50values of 0.05, 0.36, and 0.09 μM, respectively.2 1.Price, N.P.J., Jackson, M.A., Hartman, T.M., et al.Branched chain lipid metabolism as a determinant of the N-Acyl variation of Streptomyces natural productsACS Chem. Biol.16(1)116-124(2021) 2.Hering, J., Dunevall, E., Snijder, A., et al.Exploring the active site of the antibacterial target MraY by modified tunicamycinsACS Chem Biol.15(11)2885-2895(2020) 3.Duksin, D., and Mahoney, W.C.Relationship of the structure and biological activity of the natural homologues of tunicamycinJ. Biol. Chem.257(6)3105-3109(1982)
  • $686
35 days
Size
QTY
IL-15-IN-1
T116341831830-20-6
IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, effectively inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
  • $81
In Stock
Size
QTY
TargetMol | Inhibitor Sale
GLP-1 receptor agonist 15
T2047422757506-39-9
GLP-1 receptor agonist 15 (Example 4) is a GLP receptor agonist with an EC50 of 0.74 nM. It exhibits an IC50 of 10.1 μM against the hERG potassium ion channel. This compound is applicable for research in the diabetes field.
  • Inquiry Price
10-14 weeks
Size
QTY
15-LOX-1 inhibitor 2
T206355
15-LOX-1 inhibitor 2 (Compound 5i) is a potent inhibitor of 15-lipoxygenase-1 (15-LOX-1), with an IC50 of 1.7 μM. By inhibiting the activity of the 15-LOX-1 enzyme, it reduces the production of lipid peroxides, thereby preventing lipid peroxidation and protecting cells from RSL3-induced cell death. This compound is valuable for research into cell death mechanisms and oxidative stress-related conditions.
  • Inquiry Price
Size
QTY
15-LOX-1 inhibitor 1
T361692349374-37-2
9c(i472) is an inhibitor of 15-lipoxygenase-1 (15-LO-1; IC50 = 0.19 μM).1 It decreases LPS- and IFN-γ-induced NF- B activity in RAW-Blue cells when used at concentrations of 0.2, 1, and 5 μM. 9c(i472) reduces LPS- and IFN-γ-induced increases in Nos2 expression and lipid peroxidation in RAW 264.7 cells when used at a concentration of 5 μM.
  • $120
35 days
Size
QTY
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE
T37284947381-58-0
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE is a phospholipid containing stearic acid at the sn-1 position and 15(S)-HETE at the sn-2 position, formed in human peripheral monocytes activated by the calcium ionophore A23187 through direct oxidation of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PE by 15-LO. Phosphoethanolamine (PE) HETEs (PE-HETEs), including 1-stearoyl-2-15(S)-HETE-sn-glycero-3-PE, are the main source of esterified HETE in ionophore-activated monocytes.
  • $423
35 days
Size
QTY
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC
T37485154436-51-8
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC is a phospholipid that contains stearic acid at the sn-1 position and 15(S)-HETE at the sn-2 position. It is produced via oxidation of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PC by 15-lipoxygenase (15-LO).
  • $359
35 days
Size
QTY
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC
T37486154436-48-3
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC is a phospholipid that contains stearic acid at the sn-1 position and 15(S)-HpETE at the sn-2 position. It is produced via oxidation of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PC by 15-lipoxygenase (15-LO). 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC is toxic to human umbilical vein endothelial cells (HUVECs) when used at a concentration of 100 μM.
  • $423
35 days
Size
QTY
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PE
T37487154436-49-4
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PE is a phospholipid with stearic acid at the sn-1 position and 15(S)-HpETE at the sn-2 position, produced by oxidation of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PE by 15-lipoxygenase (15-LO). At concentrations of 0.6 and 0.9 μM, it increases ferroptotic cell death in wild-type and Acsl4 knockout Pfa1 mouse embryonic fibroblasts (MEFs) treated with the GPX4 inhibitor RSL3.
  • $423
35 days
Size
QTY
parp10/15-in-1
T60495
PARP10 15-IN-1 (compound 8l) is a dual inhibitor of PARP10 and PARP15, with IC50 values of 160 nM and 370 nM, respectively. It is applicable in cancer research[1].
  • $1,360
10-14 weeks
Size
QTY
hiv-1 inhibitor-15
T617972757182-99-1
HIV-1 inhibitor-15 (compound 9d) is a potent, broad-spectrum inhibitor targeting HIV-1, with EC50 values of 1.7 nM against HIV-1 WT, 4 nM against L100I, 2 nM against K103N, 6 nM against Y181C, and 9 nM against E138K. It exhibits high efficacy, favorable solubility, safety profiles, and oral bioavailability [1].
  • $1,520
6-8 weeks
Size
QTY
cox-2/15-lox-in-1
T629982413565-15-6
COX-2 15-LOX-IN-1 (Compound 14) is a dual inhibitor of COX-2 and 15-lipoxygenase (15-LOX) with IC50 values of 10.65 μM for COX-1, 0.075 μM for COX-2, and 2.98 μM for 15-LOX, exhibiting an anti-inflammatory effect.
  • $1,520
6-8 weeks
Size
QTY
PD-1/PD-L1-IN-15
T63614
PD-1 PD-L1-IN-15 is a potent PD-1 PD-L1 inhibitor (IC50: 60.1 nM) with demonstrated investigational potential for tumor immunotherapy.
  • $1,520
10-14 weeks
Size
QTY
15-PGDH-IN-1
T729502241676-74-2
15-PGDH-IN-1 is an orally active, potent inhibitor of 15-PGDH, exhibiting significant inhibitory activity against recombinant human 15-PGDH with an IC50 value of 3 nM. This compound is utilized in the research of tissue repair and regeneration.
  • $243
35 days
Size
QTY
Enpp-1-IN-15
T751262756218-99-0
Compound 88a (Enpp-1-IN-15) is an inhibitor of Ectonucleotide Pyrophosphatase Phosphodiesterase 1 (Enpp-1), exhibiting a Ki value of 0.00586 nM [1].
  • Inquiry Price
3-6 months
Size
QTY
Mcl-1 inhibitor 15
T79216
Mcl-1 Inhibitor 15 (Compound (Ra)-15), with a K i of 0.02 nM, is utilized in cancer research [1].
  • Inquiry Price
Size
QTY
C15 Ceramide (d18:1/15:0)
N-pentadecanoyl-D-erythro-Sphingosine, Ceramide (d18:1 15:0), Cer(d18:1 15:0)
T8518967492-15-3
C15 Ceramide (d18:1 15:0) is a lipid molecule that can be used in life science related research. The CAS number of C15 Ceramide (d18:1 15:0) is 67492-15-3.
  • Inquiry Price
8-10 weeks
Size
QTY
PLGA-PEG-PLGA hydrogel (LA:GA 3:1) (15% solution)
TCL-01198
PLGA-PEG-PLGA (hydrogel) (LA:GA 3:1) (15% solution) is a biodegradable thermosensitive hydrogel that undergoes phase transition at specific temperatures. It is widely applicable in drug delivery systems, tissue engineering, wound dressings, and biosensors.
  • Inquiry Price
Size
QTY
PLGA-PEG-PLGA hydrogel (LA:GA 7:1) (15% solution)
TCL-01232
PLGA-PEG-PLGA (hydrogel) (LA:GA 7:1) (15% solution) is a biodegradable, thermosensitive hydrogel capable of undergoing phase transition at specific temperatures. This compound is widely utilized in drug delivery systems, tissue engineering, wound dressings, and biosensors. Its gelation temperature is concentration-dependent, decreasing as concentration increases, and ranges from 31-34°C at concentrations of 15-20 wt%.
  • Inquiry Price
Size
QTY
15:0-18:1 DG
TN1012667889-40-1
15:0-18:1 DG is a form of diacylglycerol (DAG). It is produced by the hydrolysis of triacylglycerol (TAG) found in butter. This compound shows potential for research in obesity, cardiovascular diseases, and dietary interventions.
  • Inquiry Price
10-14 weeks
Size
QTY
4(15),11-Oppositadien-1-ol
TN299670389-96-7
4(15),11-Oppositadien-1-ol is a natural product for research related to life sciences. The catalog number is TN2996 and the CAS number is 70389-96-7.
  • $250
Backorder
Size
QTY
4(15),5,10(14)-Germacratrien-1-ol
TN299781968-62-9
4(15),5,10(14)-Germacratrien-1-ol is a natural product for research related to life sciences. The catalog number is TN2997 and the CAS number is 81968-62-9.
  • $670
Backorder
Size
QTY
Cardanol (C15:1)
TN3594501-26-8
Cardanol (C15:1), found in cashew nut shell liquid, induces mitochondria-associated apoptosis in human melanoma cells.
  • $88
In Stock
Size
QTY
β-Amyloid (1-15)
Amyloid β-Protein (1-15)
TP1229183745-81-5
β-Amyloid (1-15) (Amyloid β-Protein (1-15)) is a fragment of β-amyloid protein used in the study of Alzheimer's disease.
  • $40
In Stock
Size
QTY